MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

UnknownOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

December 31, 2021

Conditions
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceCoronavirus
Interventions
BEHAVIORAL

Questionnaire

Series of questions covering COVID-19 diagnosis and treatment, changes in myeloma treatment and care, clinical trial familiarity, health and fitness, and quality of life.

Trial Locations (1)

84043

RECRUITING

HealthTree.org (Online), Lehi

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

HealthTree Foundation

OTHER

NCT04727294 - MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey | Biotech Hunter | Biotech Hunter